Title : Inhibitory activity of FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, remdesivir, and hydroxychloroquine on COVID-19 main protease and human ACE2 receptor: A comparative in silico approach.

Pub. Date : 2021

PMID : 34568544






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Meanwhile, bexarotene and cetilistat bind more tightly to the SARS-CoV-2 main protease and the ACE2 receptor, respectively, than remdesivir, a potential treatment for COVID-19 that is the first FDA-approved drug against this virus. remdesivir angiotensin converting enzyme 2 Homo sapiens